Anzeige
Mehr »
Login
Freitag, 01.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Neuer Gold Rekord bei knapp 2.800 USD und Übernahme-Zirkus!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
535 Leser
Artikel bewerten:
(2)

EW Healthcare Partners Announces Platform Investment in Enercon Technologies

Leading electronics-focused design, engineering, and product manufacturing capabilities position Enercon for continued growth in medical devices and life sciences.

GRAY, MAINE AND NEW YORK, NY / ACCESSWIRE / May 18, 2023 / EW Healthcare Partners ("EW") announced today that it has made a platform investment in Enercon Technologies, Inc. ("Enercon" or "the Company"), becoming a majority shareholder in the business. This investment reflects the culmination of months of evaluation on behalf of the Enercon management team and its two co-founders, Walter Hebold and Ronald Marcotte, as they sought a growth-oriented partner with deep industry expertise and a shared vision for Enercon's future direction.

Founded in 1980, Enercon has grown rapidly under the leadership of its founders and CEO, Ryan Marcotte, into one of the leading contract design, engineering, and manufacturing businesses in the U.S. With particular expertise in product development and precision manufacturing for complex electronics, the Company has attracted a high-quality roster of customers across the medical device, life sciences, and industrial/defense end markets. Enercon's revenues have more than doubled since 2019, when the Company's new, state-of-the-art facility came online following $26M of investment by the founders to significantly expand capacity to ~100,000 square feet and support robust demand from customers.

"We are thrilled to partner with the Enercon team to help continue their history of impressive growth while providing additional resources and investment to further expand upon their innovative offerings for existing and future customers," said Brooks Andrews, Managing Director at EW Healthcare Partners. "Feedback from the market was clear in our diligence - Enercon excels when it comes to engineering and manufacturing capabilities, quality, and reliably serving its customers' needs - and we look forward to increasing the awareness of these core strengths in the years ahead."

"Enercon is excited to partner with EW Healthcare for the next stage of our company's growth," said Ryan Marcotte, CEO at Enercon Technologies. "EW enhances Enercon's already strong financial and operational position by providing expertise in Enercon's core end markets of Healthcare and MedTech. EW shares our vision of growing Enercon as a platform and they align with our values and culture that our employees are our most important asset. We are thrilled to have EW as our partner."

Kirkland & Ellis acted as legal advisor, PwC as financial due diligence and tax advisor, and BCG as commercial due diligence advisor for EW. BDO Capital Advisors, LLC served as financial advisor to Enercon and its shareholders.

About Enercon Technologies, Inc.

Enercon Technologies is an award-winning provider of electronic product development and manufacturing services to leading OEMs in the Medical Device, Life Sciences, Industrial and Defense end markets. Enercon builds long-term relationships with its customers through its Design+Build model which aligns goals, results in a faster time-to-market, and optimizes product launches. From its purpose-built state-of-the-art facility, Enercon's intelligent manufacturing services provide efficient and controlled production via automation, robotics and software systems that control and trace materials and processes throughout the factory. Based in Gray, Maine, Enercon is privately owned and financially strong with over 40 years of profitability since its founding in 1980.

About EW Healthcare Partners ("EW")

With over $4 billion raised since inception, EW Healthcare Partners is one of the oldest and most respected private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. Since its founding in 1985, EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been a long-term investor in over 150 healthcare companies, ranging across sectors, stages and geographies. The team is comprised of senior investment professionals located in New York, London and Houston. https://www.ewhealthcare.com/

Contact Information

Anne DeMaret
Investor Relations
ademaret@ewhealthcare.com
(281) 528-1956

SOURCE: EW Healthcare Partners

.

View source version on accesswire.com:
https://www.accesswire.com/755944/EW-Healthcare-Partners-Announces-Platform-Investment-in-Enercon-Technologies

© 2023 ACCESSWIRE
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.